1 Result

People

  1. Asher
    Asher
  2. Daly
    Daly
  3. De Stanchina
    De Stanchina
  4. Delasos
    Delasos
  5. Khodos
    Khodos
  6. Kurzatkowski
    Kurzatkowski
  7. Ladanyi
    Ladanyi
  8. Lui
    Lui
  9. Mattar
    Mattar
  10. Odintsov
    Odintsov

Groups

  1. Department of Medicine (1)
  2. GSK Faculty (1)
  3. Human Oncology and Pathogenesis Program (1)
  4. Sloan Kettering Institute Postdocs (1)
  5. Solid Tumor Oncology Division (1)
  6. Thoracic Oncology (1)
  7. Tow Center for Developmental Oncology (TCDO) (1)
  1. "her3 antibody"
  2. "Jo Weng Allan Lui"
Formats
  1. Journal Article (1)
Groups
  1. Department of Medicine (1)
  2. GSK Faculty (1)
  3. Human Oncology and Pathogenesis Program (1)
  4. Sloan Kettering Institute Postdocs (1)
  5. Solid Tumor Oncology Division (1)
  6. Thoracic Oncology (1)

More Groups

People
  1. Christopher Kurzatkowski (1)
  2. Elisa De Stanchina (1)
  3. Igor Odintsov (1)
  4. Inna Khodos (1)
  5. Jo Weng Allan Lui (1)
  6. Lukas Delasos (1)

More People

Years
  1. 2021 (1)
Publications
  1. Journal of Thoracic Oncology (1)
Publishers
  1. Elsevier Inc. (1)

Results (1)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Novel preclinical patient-derived lung cancer models reveal inhibition of HER3 and MTOR signaling as therapeutic strategies for NRG1 fusion-positive cancers
    Journal Article

    Odintsov, I.; Mattar, M. S.; Lui, A. J. W.; Offin, M.; Kurzatkowski, C.; Delasos, L.; Khodos, I.; Asher, M.; Daly, R. M.; Rekhtman, N.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save